Background. Evidence-based guidelines are needed to inform rehabilitation practice,
D
ose is a critical parameter contributing to the effectiveness of therapeutic interventions for motor and behavioral recovery after stroke. [1] [2] [3] [4] Exercise parameters that contribute to a dose-response relationship in physical rehabilitation consist of frequency (number of training sessions per week), intensity (cardiopulmonary workload), duration (total number of treatment sessions) and type. 5 The National Center for Medical Rehabilitation Research claimed an essential need for evidence-based guidelines to inform rehabilitation practice relative to intervention timing, intensity, and duration for people after stroke. 6 More recently, a Cochrane review called for research to specifically investigate the effects of different durations of gait training employing treadmill with body-weight support on walking recovery after stroke. 7 Intervention response must be examined in the context of relevant and functionally important outcomes. Gait speed is regarded as a significant, sensitive, and reliable marker of deficit severity and functional community walking ability. [8] [9] [10] [11] [12] [13] Additionally, although stroke survivors often achieve sufficient recovery to perform some limited walking, the ability to walk longer distances, as needed for community ambulation, often remains compromised. Therefore, walking distance is also an important and functionally relevant outcome measure to assess when examining the dose-response relationship. Thirdly, as a return to home and community ambulation is a primary rehabilitation goal for many survivors after stroke, 14 recording steps taken outside of the clinic or laboratory setting is informative to determine if gait speed and endurance improvements are translated into a patient's daily life.
The design of the multisite, Phase III Locomotor Experience Applied PostStroke (LEAPS) randomized controlled trial, 15 provides an opportunity to examine intervention response in relationship to number of intervention sessions completed. The trial's primary analysis determined that the task-specific LTP program, provided 2 or 6 months after stroke, was not superior in improving walking ability compared to the impairment-focused home exercise program (HEP). 15 Both interventions resulted in over 50% of the study population improving walking ability, defined as transitioning to a higher functional walking level based on gait speed at 1-year after stroke (eg, from severe to moderate impairment or from moderate to mild impairment). Secondary analyses of the LEAPS trial data determined that LTP and HEP were more effective than usual care physical therapy in improving walking ability at 6 months after stroke 16 and that a younger age and higher Berg Balance Scale score were predictors of response to the trial intervention. 17 The LEAPS randomized controlled trial was also designed to specifically examine the dose-response relationship, defined by number of training sessions, to successive epochs of physical therapy, from 12 to 24 to 36 cumulative sessions, on walking outcomes.
The number of training sessions for the LEAPS trial was based on preliminary work on locomotor training indicating efficacy, 18 impairment-based training indicating efficacy, 19 and relevance of frequency (eg, 3 times per week) to current clinical practice after discharge from acute rehabilitation. The relationship of number of training sessions to intervention timing (ie, point of delivery after stroke) and stroke severity is also relevant to rehabilitation effectiveness and thus to treatment planning. [20] [21] [22] Greater number of sessions may improve outcomes, but the effect of increasing the number of sessions may also depend on timing of intervention delivery and initial severity of impairment.
The goal of this secondary analysis is to investigate the response to number of training sessions on walking outcomes and targets 2 questions to inform rehabilitation practice. First, "Does a successively greater number of intervention sessions result in a greater improvement in walking speed and walking distance?" Second, "Does severity of initial walking impairment interact with number of sessions, such that people with greater walking impairment benefit from more sessions when comparing (a) interventions (HEP and LTP) or (b) timing of intervention delivery (E-LTP and L-LTP)?
Methods

Design Overview
The LEAPS trial was a multicenter, single-blind randomized controlled trial, with participants stratified by 2-month poststroke walking impairment (severe, <0.40 m/s; moderate, 0.40-0.79 m/s), and randomized to the E-LTP, L-LTP, or HEP groups (proportions 7:6:7). The LEAPS protocol is described at clinicaltrials.gov and has been reported previously. 23 Ethics review boards at all participating centers approved the protocol. All participants provided written informed consent. An independent medical monitor and a data safety monitoring board appointed by the National Institutes of Health oversaw the conduct, safety, and efficacy of the trial and monitored adverse events.
Setting and Participants
Participants were recruited from 6 inpatient rehabilitation sites in California and Florida. Inclusion criteria were age ≥ 18 years; stroke within 45 days and ability to be randomized at 2 months after stroke; residual paresis in the lower extremity; ability to walk 3 meters (10 ft) with no more than 1-person assistance; ability to follow a 3-step command; physician approval for participation; self-selected 10-m walking speed of less than 0.8 m/s; and living in the community at the time of randomization. The primary criteria for exclusion were dependency on assistance in activities of daily living before the stroke, exercise contraindications, preexisting neurological disorders, and inability to travel to the treatment site. 23 Although the primary LEAPS trial analysis was an intent-to-treat analysis and thus the data were imputed when necessary, the present analysis of response in relation to number of training sessions used solely the data from participants receiving the required number of sessions. Thus, only participants who received a total of 30 to 36 sessions and had walking speed measurements after 12, 24, and 30 to 36 sessions of intervention were included and defined as "completers." For the primary LEAPS analysis, a minimum of 30 sessions was necessary for the intervention to be considered complete.
Randomization and Interventions
The LTP and HEP programs were delivered 3 times per week for 90-minute sessions over a 12-to 16-week period for a total of 30 to 36 sessions. Intervention protocols have been previously reported. 23 LTP included task-specific walking training on a treadmill with partial body weight support. The aim of the first session was to train at a maximum of 40% body-weight support, with a minimal speed of 0.89 m/s, with manual assistance as needed for proper kinematics for a total duration of 20 minutes (four 5-minute bouts) of stepping, followed by a progressive overground walking program for 15 minutes. The long-term aim of the LTP was for participants to be able to walk independently at 0% body-weight support, within a range of 0.89 m/s to 1.34 m/s with a maximum goal of independent stepping for 30 continuous minutes. Progression parameters included stepping duration, speed, weight-bearing load, and level of assistance. The home exercise programs included progressive flexibility, range of motion, upper-and lower-extremity strengthening, coordination, and static and dynamic balance exercises provided by a physical therapist in the home.
Common to both interventions was that participants were continually challenged and progressed. For LTP, at least 1 of the training parameters (stepping duration, speed, weight-bearing load or level of assistance) was progressed at each intervention session. For HEP, at least 1 of the exercises was progressed with either an increased number of repetitions or, for the strengthening exercises, level of resistance. Progression was individualized for each participant across the 36 sessions based on their initial ability and needs. Progression guidelines for both interventions were maintained throughout the course of the LEAPS trial and did not change with epoch of treatment (first, second, and third wk; 12 weeks). In addition to the LTP and HEP interventions, all participants were allowed to receive any prescribed usual and customary care during the trial intervention. Study participants were not to engage in gait training on a treadmill with body-weight support, but no other restrictions were placed on the type or amount of usual care. 24 
Outcomes and Follow-up
This secondary analysis used the LEAPS randomized controlled trial data from pretraining (2 months after stroke for E-LTP and HEP and 6 months after stroke for L-LTP), and after 12, 24, and 30 to 36 intervention sessions. Changes in 10-m walking speed 25 and distance walked in 6 minutes 26 were assessed after each successive round of 12 intervention sessions. Methods for obtaining these 2 measurements have been reported previously. 24, 27 
Data Analysis
To assess the effect of intervention group, number of training sessions (12, 24 , and 36), impairment severity and their interactions, longitudinal analyses (PROC GLIMMIX in SAS) were performed on each of the outcomes (walking speed and walking distance), including a random subject effect. For each dependent variable, 12 linear contrast tests were performed to assess the effect of intervention group (comparing the HEP vs E-LTP and E-LTP vs L-LTP) by number of training sessions and impairment severity. Similarly, 18 linear contrasts were tested to assess the changes from pretraining to 12th session, 12th to 24th sessions, and 24th to 36th sessions by intervention group and severity. Lastly, 3 linear contrast tests for each of the outcomes were performed to assess the difference between the moderate and severe group on the change of each outcome values from pretraining to 12th session, 12th to 24th sessions, and 24th to 36th sessions.
To adjust for multiple testing, stepdown procedures were applied to the n (=3, 12, and 18) contrast tests for each independent variable. 28 More specifically, the P values were sorted in increasing order: P(1), …, P(n). We compared P(k) with .05/(n+1-k) and identified the smallest k satisfying P(k) > .05/(n+1-k). The first (k-1) P values were considered to be statistically significant. SAS software (SAS, Cary, North Carolina), version 9.1, was used to perform all statistical analyses.
Role of the Funding Source
This work was supported by funding from National Institute of Neurological Disorders and Stroke and the National Center for Medical Rehabilitation Research (RO1 NS050506) as well as VA Rehabilitation R&D Grant B6793C. The body-weight support treadmill systems and the cost of all study assessments and interventions were supported by funding from the National Institutes of Health. The funding sources had no role in the design, conduct, or reporting of this study.
Results
From the original LEAPS randomized controlled trial cohort of 408 participants, 347 (85%) completed 30 to 36 intervention sessions and were identified as "completers." Compared to noncompleters (n=61; 15%), completers had the following baseline characteristics: fewer hospitalizations, greater proportion of large vessel distribution stroke, shorter Trail-Making Test time, better Wechsler Adult Intelligence Scale (WAIS) digit symbol subscale, lower prevalence of diabetes, lower age at stroke onset, and fewer falls. The remaining analyses were conducted on those identified as completers. The cohort was equally distributed across the 3 training groups: HEP=34.0%, E-LTP=33.7%, and L-LTP=32.3% (Tab. 1). Whereas the baseline characteristics of the 3 treatment groups were balanced in the primary LEAPS analysis, 15 in the present analysis of the completer subgroup, participants in the E-LTP group were younger, had higher NIHSS score, and had lower extremity Fugl-Meyer (LEFM) sensory and motor scores compared to the other 2 groups (P < .05).
Progression of the Intervention
As dictated by the study design, participants were continually challenged and progressed throughout the 36 sessions. For those in the 2 LTP groups, the training parameters of total minutes of stepping on the treadmill per session, minimum percent body-weight support 
Walking Speed Across Session Intervals
Walking speed improved significantly following the initial 12 sessions compared to pretraining within each training group (E-LTP, HEP, and L-LTP) and severity level (moderate and severe).
Further significant improvement in walking speed resulted from the second set of 12 sessions (24 total) for all groups except those in the L-LTP group with moderate severity. Walking speed improvement at session 36, relative to walking speed after 24 sessions, was restricted to the E-LTP severe and the L-LTP moderate and severe groups (Tab. 3; Fig. 1 ). Weak responses during the 24-to 36-session epoch could reflect a reduced number of sessions (30) (31) (32) (33) (34) (35) for some participants during this epoch. A regression analysis to determine the effect of additional training sessions after 30 on change in gait speed, including all participants, showed that each session was associated with a 0.011 m/s walking speed change (P=.003).
Walking Distance Across Session Intervals
We observed similar results for walking distance as for speed. Walking distance improved significantly following the initial 12 sessions compared to pretraining within each training group (E-LTP, HEP, and L-LTP) and severity level (moderate and severe). Further significant improvement in walking distance resulted following the second set of 12 sessions (24 total) for all groups except those in the L-LTP group with moderate severity. The improvement in walking distance achieved with 25 to 36 sessions, compared to walking distance at the end of 24 sessions, was only observed in E-LTP severe, HEP moderate, and L-LTP moderate groups (Tab. 3; Fig. 2 ).
Discussion
We investigated the impact of number of sessions of 2 different exercise interventions in which content and timing of therapy were controlled in a systematic way. 29 This secondary analysis from the completed LEAPS randomized controlled trial examined the immediate relationship between number of training sessions and walking outcomes over 3 successive epochs of 12 intervention sessions (after 12 sessions (18 hours of treatment), 24 sessions (36 hours of treatment), and 30 to 36 sessions (45-54 hours Step Activity Monitor total steps, median (25th percentile-75th percentile) a P values of the 18 contrast t tests for each outcome were adjusted with a step-down procedure. The significant findings are shown in bold type.
of treatment)), compared across intervention type and level of walking severity.
We found that, at both 2 and 6 months after stroke, participants benefited from up to 24 sessions of locomotor training or strength and balance exercises with the single exception of the L-LTP moderate group, which failed to show significant gains in gait speed during the second 12 treatment epoch. Significant improvements were observed with greater than 24 sessions in severely impaired participants receiving LTP at 2 months after stroke and in both L-LTP groups.
Although participants in all groups continued to increase walking speed with further treatment, up to and including 36 sessions, our data revealed progressively diminishing returns, best illustrated in Figure 2 . Walking speed gains during the 25-to 36-session epoch were statistically significant only for the E-LTP severe group and for the L-LTP moderate and severe groups (Tab. 3). These findings for walking speed were substantially paralleled by those for walking distance (Tab. 3, Fig. 2 
Walking Improvement Beyond 6 Months After Stroke Onset
Walking speed and distance improved for all L-LTP participants through all 3 training epochs with 2 exceptions, as noted (Tab. 3). These improvements in response to an intense, progressive exercise intervention indicate that these participants had not plateaued in their recovery at 6 months after stroke, as is often reported in the stroke literature, 31 but rather remained responsive to an exercise stimulus. It should be noted that participants in the L-LTP group began the study intervention at a higher level of function compared to the E-LTP group (either because of natural recovery, usual care, or both).
Limitations
These results are limited to the 2 interventions studied in the LEAPS randomized controlled trial: locomotor training and an impairment-based program of strength and balance exercises. Additionally, the LEAPS randomized controlled trial only enrolled people who had some ability to ambulate and had passed extensive cardiac screening, including an exercise tolerance test. Of those participants who demonstrated further gains with treatment beyond 24 intervention sessions, we do not know if more than 36 sessions would be of benefit as the study design precluded determination of a plateau. Finally, the LEAPS trial was designed as a walking recovery, not a cardiac rehabilitation trial. As such, limits were conservatively set on HR response during exercise. HR limitations approved for this protocol may have prevented participants from walking faster, longer, or with greater limb loading, which may have translated into blunted responses.
Conclusions
Understanding the optimal number of sessions of a given therapeutic intervention is critical to the implementation of evidence-based physical therapist practice. This study demonstrated that, in general, adults who dwelled in the community and had some ambulation capability showed improvements in walking recovery after up to 24 sessions of locomotor training or strength and balance exercises at both 2 and 6 months after stroke. Increasing number of treatment sessions yields steadily diminishing returns in terms of improvement in gait speed and walking distance. Even though some groups did exhibit statistically significant gains during the 25-to 36-session treatment epoch, the rate of gait speed gain between 30 and 36 treatments was such that total expected gain during this epoch would be below the minimal clinically important difference of 0.16 m/s. These results point to the imperative of tracking response to treatment over time to accurately assess when individual patients are reaching a plateau.
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